AlphaGrep UK’s Eli Lilly LLY Stock Holding History

AlphaGrep UK’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$852K	Buy	710 +133	+23%	+$136K	0.25%	69
2026 Q1	$531K	Buy	577 +59	+11%	+$59.8K	0.15%	221
2025 Q4	$557K	Buy	+518	New	+$495K	0.19%	173

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AlphaGrep UK's LLY Position: Q2 2026 in Review

AlphaGrep UK increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $136K and bringing the position to 710 shares worth $852K. The position accounts for 0.25% of the portfolio, ranked #69.

AlphaGrep UK first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

AlphaGrep UK held 710 shares of Eli Lilly worth $852K as of Q2 2026.
AlphaGrep UK bought 133 Eli Lilly shares in Q2 2026, an estimated $136K.
Eli Lilly made up 0.25% of AlphaGrep UK's portfolio in Q2 2026, its #69 holding.
AlphaGrep UK first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.